NERV

Over the past six months, Minerva Neurosciences announced participation in investor conferences in August and May 2026, and provided its Second Quarter 2026 Financial Results and Business Updates in August 2026. The company established a Scientific Advisory Board in June 2026 to advance its pipeline. SEC filings in August 2026 revealed significant ownership disclosures from Balyasny Asset Management (9.99%) and Farallon group (9.7%). Anthony Aliquo was promoted to chief accounting officer in August 2026. While HC Wainwright increased Q1 2026 EPS estimates, the company later missed quarterly earnings expectations by $0.04 EPS. Short interest in NERV significantly increased in March and April 2026. As of October 9, 2026, the stock gained 23.7% over the past year and 56.19% over the last 52 weeks as of October 3, 2026, but experienced decreases of 22.8% over the prior month, 2.97% compared to the previous week, and 29.83% over the last month as of October 8, 2026. The next earnings report is anticipated on November 11, 2026.